Medtronic Completes Acquisition of CathWorks

Stereotaxis Acquires Robocath

April 16, 2026

Medical Devices

Stereotaxis has entered into a definitive agreement to acquire Robocath, a venture-backed developer of robotic technologies for interventional cardiology and neurointerventions. The deal is designed to strengthen Stereotaxis’ position across the full spectrum of endovascular procedures by combining Stereotaxis’ magnetic navigation technology with Robocath’s mechanical multi-device control platform.

Medtronic to Acquire Scientia Vascular

March 10, 2026

Medical Devices

Medtronic entered into a definitive agreement to acquire Scientia Vascular in a $550 million deal, with customary adjustments and potential earn-out/milestone payments. The acquisition combines Scientia’s neurovascular access devices (guidewires and catheters) with Medtronic’s existing neurovascular therapeutic portfolio to support faster and more reliable treatment for complex stroke cases.

Ra Medical Systems Acquires Catheter Precision in Stock-for-Stock Reverse Merger

September 12, 2022

Medical Devices

Ra Medical Systems entered into a definitive agreement to acquire privately held Catheter Precision through a stock-for-stock reverse merger in which Catheter Precision will become a wholly owned subsidiary. The combined company will focus on the cardiac electrophysiology market and is expected to close before the end of 2022, subject to shareholder approval and other customary closing conditions.

Cirtec Medical Acquires Cardea Catheter Innovations

July 26, 2021

Medical Devices

Cirtec Medical has acquired Cardea Catheter Innovations, a San Jose-based manufacturer of minimally invasive catheter devices and complex delivery systems. Cardea will integrate into Cirtec's NovelCath brand to expand the company's interventional capabilities across structural heart, electrophysiology, and neurovascular markets and will relocate into Cirtec's new San Jose Center of Excellence.

Haemonetics Acquires Cardiva Medical

January 20, 2021

Medical Devices

Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.

Cirtec Medical Acquires NovelCath

December 17, 2020

Medical Devices

Cirtec Medical Corporation has acquired NovelCath, a vertically integrated manufacturer of catheter delivery systems based in Brooklyn Park, Minnesota. The acquisition expands Cirtec's capabilities in minimally invasive interventional and structural heart device manufacturing and establishes the NovelCath facility as Cirtec's Center of Excellence for Catheters and Delivery Systems.